Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV Infection
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection
- Status
- COMPLETED
- Phase
- PHASE3
Comparative Efficacy of Fixed-dose Combination Sofosbuvir + Ledipasvir, 8 vs. 12 Weeks in Chronic Hepatitis C Genotype 6
- Status
- COMPLETED
- Phase
- PHASE4
Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection
- Status
- TERMINATED
- Phase
- PHASE4
Atripla to Stribild Switch Study to Evaluate Sleep Disturbances
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate the Effects of MBX-8025 in Patients With HoFH
- Status
- COMPLETED
- Phase
- PHASE2
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
- Status
- COMPLETED
- Phase
- PHASE3
Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Study to Assess the Long-term Safety and Efficacy of Tirabrutinib in Adults With Relapsed/Refractory B-cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Sequential Regimen of Bendamustine-Debulking Followed by CAL-101 and GA101-Induction and -Maintenance in CLL (CLL2-BCG)
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Adults Receiving Ruxolitinib as Therapy for Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis With Progressive or Relapsed Disease
- Status
- TERMINATED
- Phase
- PHASE1
Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality
- Status
- COMPLETED
- Phase
- N/A
Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries
- Status
- WITHDRAWN
- Phase
- PHASE4
Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection
- Status
- COMPLETED
- Phase
- PHASE2